What Is Oculis Holding AG (OCS) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Oculis Holding AG's intrinsic value is estimated at $8.69, suggesting the stock is overvalued at its current price of $13.12. With 7 out of 8 models flagging downside (-33.8% average return), the market may be pricing in unsustainable growth. Notably, First Chicago sees the most upside at +230.3% (fair value: $43.34), while ML-RIV is the most conservative at -97.8% ($0.28). The spread between these extremes — +328.2% — reveals how different analytical frameworks can reach starkly different conclusions.
What Do the Models Say About OCS?
8 of 13 models are currently active for OCS. Of these, 1 model suggests upside while 7 models suggest overvaluation. The Bayesian DCF estimates OCS's intrinsic value at $5.68, implying -56.7% downside from the current price. See which stocks rank higher →
How Does OCS Rank in Pharmaceutical Preparations?
Among 431 Pharmaceutical Preparations stocks, OCS ranks #246 by Quality of Company score. CirclFi's QOC score of 4.7/10 evaluates 32 fundamental signals. A score of 4.7 reflects mixed fundamentals.
See all Most Undervalued Pharmaceutical Preparations Stocks →
Within the Pharmaceutical Preparations space, Oculis Holding AG competes in an environment where clinical trial success rate often separates market leaders from laggards. Understanding these industry-specific dynamics is essential context for interpreting our model outputs.
Is OCS a Value Trap?
CirclFi's Value Trap algorithm assigns OCS a score of 45/100 (WARN). This is a warning signal. Additional research into recent 10-Q filings is recommended. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
8 of 13 models are active for Oculis Holding AG. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi 32-factor quality framework, Oculis Holding AG's fundamental quality profile registers 4.7/10. This mixed score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.
The gap between the most bullish and bearish model spans +328.2% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every OCS valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across OCS's 8 active models, average confidence is 19%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad